ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China · Delayed Price · Currency is CNY 22.93
-0.36 (-1.55%)
Sep 10, 2026, 1:14 PM CST
ChengDu ShengNuo Biotec Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,132 | 5,948 | 2,886 | 3,158 | 1,778 | 2,929 | |
Market Cap Growth | -22.79% | 106.10% | -8.63% | 77.68% | -39.31% | - |
Enterprise Value | 5,452 | 6,221 | 3,054 | 3,124 | 1,495 | 2,550 |
Last Close Price | 23.29 | 26.73 | 12.92 | 14.08 | 7.88 | 12.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.18 | 37.66 | 57.69 | 44.90 | 27.57 | 47.82 |
Forward PE | 23.46 | 23.96 | 20.17 | 34.71 | - | - |
PS Ratio | 5.63 | 8.02 | 6.33 | 7.26 | 4.49 | 7.58 |
PB Ratio | 4.49 | 5.62 | 3.14 | 3.59 | 2.15 | 3.73 |
P/TBV Ratio | 4.82 | 6.09 | 3.29 | 3.74 | 2.25 | 3.91 |
P/FCF Ratio | 111.18 | 182.00 | - | - | - | - |
P/OCF Ratio | 27.89 | 33.33 | 114.18 | 37.25 | 18.59 | 55.88 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.98 | 8.39 | 6.70 | 7.18 | 3.78 | 6.60 |
EV/EBITDA Ratio | 15.81 | 23.34 | 30.35 | 29.77 | 16.84 | 30.48 |
EV/EBIT Ratio | 20.02 | 29.54 | 46.23 | 40.42 | 22.99 | 38.80 |
EV/FCF Ratio | 118.11 | 190.37 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.59 | 0.56 | 0.53 | 0.30 | 0.12 | 0.04 |
Debt / EBITDA Ratio | 1.95 | 2.21 | 4.79 | 2.49 | 1.14 | 0.39 |
Debt / FCF Ratio | 14.58 | 18.04 | - | - | - | - |
Net Debt / Equity Ratio | 0.28 | 0.27 | 0.27 | -0.01 | -0.33 | -0.48 |
Net Debt / EBITDA Ratio | 0.93 | 1.08 | 2.42 | -0.07 | -3.04 | -4.53 |
Net Debt / FCF Ratio | 6.94 | 8.82 | -1.10 | 0.04 | 6.70 | 32.07 |
Asset Turnover | 0.48 | 0.41 | 0.31 | 0.36 | 0.38 | 0.50 |
Inventory Turnover | 1.10 | 1.03 | 0.81 | 0.99 | 1.20 | 1.16 |
Quick Ratio | 1.06 | 0.79 | 0.69 | 1.64 | 2.29 | 3.28 |
Current Ratio | 1.97 | 1.41 | 1.32 | 2.53 | 2.96 | 4.01 |
Return on Equity (ROE) | 19.11% | 15.98% | 5.54% | 8.24% | 8.00% | 10.02% |
Return on Assets (ROA) | 8.89% | 7.35% | 2.79% | 3.98% | 3.94% | 5.30% |
Return on Invested Capital (ROIC) | 15.91% | 14.02% | 5.26% | 9.49% | 12.03% | 15.98% |
Return on Capital Employed (ROCE) | 17.50% | 16.10% | 6.00% | 7.20% | 7.40% | 8.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.98% | 2.66% | 1.73% | 2.23% | 3.63% | 2.09% |
FCF Yield | 0.90% | 0.55% | -7.70% | -6.12% | -2.26% | -0.40% |
Dividend Yield | 1.06% | 0.94% | 0.55% | 0.72% | 1.16% | 0.85% |
Payout Ratio | 36.37% | 22.79% | 68.30% | 41.49% | 41.59% | 0.04% |
Buyback Yield / Dilution | -1.43% | -1.03% | 1.60% | -2.04% | -10.22% | -20.09% |
Total Shareholder Return | -0.37% | -0.09% | 2.15% | -1.32% | -9.06% | -19.23% |